Skip to Main Content

Paper Details

Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.
Eur J Prev Cardiol
16
2022
FH, HeFH, LDL-C, Patients, alirocumab, cholesterol, familial hypercholesterolaemia, headache, heterozygous familial hypercholesterolaemia, hypercholesterolaemia, kexin type 9, myalgia, nasopharyngitis, patients, statin, subtilisin/, very-high low, very-high low-density lipoprotein cholesterol
Author NameAffiliation
Daniel GaudetECOGENE-21 and Clinical Lipidology Unit, Universite de Montreal
Maciej BanachMedical University of Lodz
  • 1 - 2

Datasets

Release 1.2